How Much Does Metformin Cost in Delaware in 2026?

Delaware Retail Cash Prices for Metformin in 2026

The average cash price for generic metformin across Delaware retail pharmacies in 2026 is approximately $8 per month for a standard 30-day supply of metformin hydrochloride 500 mg or 850 mg immediate-release tablets. That figure reflects what uninsured patients pay without discount cards or coupons. The manufacturer list price for generic metformin sits around $40 per month, but retail competition among generics keeps actual shelf prices well below that number.

Price variation exists between pharmacies. A Walgreens in Wilmington may charge $10 for a 30-day supply of metformin 1 to 000 mg tablets while a Rite Aid in Dover prices the same quantity at $6. Independent pharmacies in Sussex County sometimes match or beat chain pricing. The extended-release (ER) formulation typically costs $2 to $5 more per month than immediate-release at most Delaware locations.

Metformin earned FDA approval in 1995 as the first biguanide authorized for type 2 diabetes in the United States. Because the drug has been off-patent for decades, multiple generic manufacturers produce it, which is the primary reason prices remain so low. The UKPDS 34 trial (N=1,704) demonstrated that metformin reduced diabetes-related mortality by 42% in overweight patients with type 2 diabetes compared to conventional treatment, establishing it as a first-line therapy that has remained the global standard for over 25 years [1].

Delaware Medicaid Coverage for Metformin

Delaware Medicaid covers metformin with prior authorization. The prior authorization requirement does not mean the drug is hard to get. It means the prescriber must confirm a qualifying diagnosis (type 2 diabetes or, in some cases, prediabetes or polycystic ovary syndrome) before Medicaid reimburses the pharmacy.

For patients enrolled in Delaware's Medicaid managed care plans (Diamond State Health Plan and Diamond State Health Plan Plus), the copay for generic metformin is $0 to $3 per prescription. Metformin sits on the preferred drug list as a Tier 1 generic, which gives it the lowest copay tier available [2]. Patients who qualify for both Medicaid and Medicare (dual-eligible beneficiaries) pay no copay for metformin under most circumstances.

The American Diabetes Association Standards of Care recommends metformin as first-line pharmacotherapy for type 2 diabetes, stating: "Metformin should be initiated at the time of type 2 diabetes diagnosis unless contraindications exist" [3]. This guideline consensus is one reason state Medicaid programs, including Delaware's, rarely deny prior authorization for the drug.

To initiate a PA for metformin through Delaware Medicaid, the prescriber submits a brief clinical form documenting the diagnosis and confirming that eGFR is above 30 mL/min/1.73 m². Approval typically takes 24 to 72 hours. Expedited review is available for urgent situations.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans operating in Delaware place generic metformin on Tier 1, the lowest-cost formulary tier. That translates to copays of $0 to $4 per month at in-network pharmacies. Some plans with $0 preventive drug benefits cover metformin with no copay at all.

Major insurers active in Delaware's individual and employer markets include Highmark Blue Cross Blue Shield of Delaware, Aetna, and AmeriHealth Caritas. All three list generic metformin on their 2026 formularies without step therapy requirements. Highmark's standard plan, for example, charges $1 for a 30-day supply of metformin 500 mg IR tablets at preferred pharmacies.

Medicare Part D plans in Delaware also classify metformin as a Tier 1 generic. Under the Inflation Reduction Act provisions that took full effect in 2025, Medicare beneficiaries now have an annual out-of-pocket cap of $2,000, though metformin is unlikely to meaningfully contribute toward that cap given its low cost [4]. A 2023 analysis published in Annals of Internal Medicine found that average monthly out-of-pocket spending on metformin for Medicare Part D enrollees was $2.30, making it one of the least expensive diabetes medications on any formulary [5].

Compounded Metformin in Delaware: Legality and Pricing

Compounded metformin is legal in Delaware through licensed 503A compounding pharmacies. A 503A pharmacy operates under a patient-specific prescription from a licensed prescriber and is regulated by the Delaware Board of Pharmacy under state and federal law (Section 503A of the FD&C Act).

Why would someone compound a drug that already costs $8 per month as a commercial generic? A few clinical scenarios justify it. Some patients need a specific dose (say 750 mg) that is not commercially available in tablet form. Others require a liquid formulation, a flavored suspension for palatability, or a capsule without a specific inactive ingredient that triggers an allergy or GI intolerance. The extended-release matrix in commercial metformin ER tablets occasionally causes "ghost tablets" in stool, and a compounded ER alternative can resolve that issue for some patients.

Pricing from Delaware 503A pharmacies varies. Some compounded metformin preparations cost as little as $0 per month when bundled into a telehealth or membership pharmacy program. Stand-alone compounded prescriptions typically range from $15 to $45 per month depending on the formulation, dose, and quantity.

The FDA's guidance on compounding specifies that compounded drugs must not be copies of commercially available products unless the prescriber documents a clinical difference for the specific patient [6]. Delaware pharmacies follow this requirement, meaning the prescription must note the medical reason the commercial product is unsuitable.

Telehealth Prescribing of Metformin in Delaware

Delaware permits telehealth prescribing of metformin. A licensed prescriber can evaluate a patient via video or audio visit and write a metformin prescription without an in-person exam, provided the visit meets the standard of care for the diagnosis.

Delaware's telehealth parity law, codified in Title 24 of the Delaware Code, requires insurers to cover telehealth visits at the same rate as in-person visits [7]. This means the telehealth appointment itself is covered by insurance at no additional cost beyond the normal copay. The patient then fills the metformin prescription at any Delaware pharmacy (or mail-order pharmacy) as usual.

Several national telehealth platforms operate in Delaware and prescribe metformin for type 2 diabetes, prediabetes, insulin resistance, and off-label uses such as PCOS. Consultation fees for uninsured patients on these platforms range from $30 to $75 per visit, with some offering subscription models that include the medication.

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association, has noted: "Telehealth has become a permanent fixture in diabetes management, not a pandemic workaround. It expands access particularly in underserved areas" [3]. Kent and Sussex counties in Delaware, which have fewer endocrinologists per capita than New Castle County, benefit from this expanded access.

Discount Programs and Savings Cards for Metformin in Delaware

Even at $8 per month, patients can reduce metformin costs further. Free discount card programs from GoodRx, RxSaver, and SingleCare typically show Delaware pharmacy prices between $3 and $7 for a 30-day supply of metformin 500 mg or 1 to 000 mg tablets. These cards work for uninsured patients or those whose insurance copay exceeds the discount price.

Walmart and Costco pharmacies in Delaware offer metformin on their $4 generic drug lists. A 30-day supply of metformin 500 mg, 850 mg, or 1 to 000 mg IR tablets costs $4 at Walmart without insurance or a discount card. Costco does not require a membership to use its pharmacy in Delaware, making this a viable option for non-members.

The Mark Cuban Cost Plus Drug Company (CostPlusDrugs.com) sells metformin for a flat markup of 15% above manufacturing cost plus a $5 dispensing fee, shipped to Delaware addresses. Their 2026 price for 60 tablets of metformin 500 mg IR is approximately $4.20 including shipping.

For patients on high-deductible health plans who have not yet met their annual deductible, a 2022 study in Diabetes Care found that out-of-pocket spending on metformin before deductible was met averaged $14.50 per month [8]. Using a discount card in this scenario saves $6 to $10 compared to paying the pharmacy's uninsured rate directly through the insurance's pre-deductible pricing.

Metformin Formulations and How They Affect Price

Metformin is available in several formulations, and the choice impacts both cost and tolerability. Immediate-release (IR) tablets come in 500 mg, 850 mg, and 1 to 000 mg strengths. Extended-release (ER) tablets come in 500 mg, 750 mg, and 1 to 000 mg strengths. An oral solution (500 mg/5 mL) exists for patients who cannot swallow tablets.

The IR formulation is the cheapest. Generic metformin IR in Delaware runs $4 to $10 per month depending on the pharmacy and quantity. Generic metformin ER costs $6 to $15 per month. The oral solution is the most expensive commercial formulation, often $30 to $60 per month without insurance.

Brand-name Glucophage (IR) and Glucophage XR (ER) are still technically available but rarely dispensed because generic versions are therapeutically equivalent and dramatically less expensive. If a prescriber writes "Glucophage" with "DAW" (dispense as written), the patient would pay significantly more. The FDA's Orange Book confirms therapeutic equivalence (AB rating) for all approved generic metformin products [9].

The ADA's 2024 Standards of Care notes: "Extended-release metformin may improve gastrointestinal tolerability and can be considered for patients who experience GI side effects with the immediate-release formulation" [3]. In practice, many Delaware prescribers start patients on IR and switch to ER only if GI symptoms (nausea, diarrhea, bloating) persist beyond the first four to six weeks of dose titration.

Off-Label Uses and Coverage Implications in Delaware

Metformin's $4 to $8 price point makes insurance coverage less of a barrier for off-label uses, but coverage policies still affect some patients. The drug is prescribed off-label for prediabetes, PCOS, gestational diabetes prevention, and weight management. It has also attracted research interest for potential anti-aging and cancer-preventive properties, with the TAME (Targeting Aging with Metformin) trial currently enrolling subjects to test these hypotheses [10].

Delaware Medicaid covers metformin for prediabetes with prior authorization if the prescriber documents elevated fasting glucose (100 to 125 mg/dL) or HbA1c of 5.7% to 6.4%. The Diabetes Prevention Program trial (N=3,234) showed metformin reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years compared to placebo [11]. The 15-year follow-up confirmed persistent benefit, with metformin reducing diabetes incidence by 18% over the long term.

For PCOS, commercial insurers in Delaware generally cover metformin when the diagnosis is documented, even though PCOS is not an FDA-approved indication. The Endocrine Society's 2023 PCOS guideline recommends metformin as an adjunct to lifestyle modification for metabolic features of PCOS [12].

Coverage for weight management without a diabetes or PCOS diagnosis is less consistent. Most Delaware insurers do not cover metformin solely for weight loss, but the out-of-pocket cost is low enough that patients often pay cash.

How to Get the Lowest Metformin Price in Delaware

Start by asking your prescriber for generic metformin IR. Confirm the prescription is written for the generic (metformin hydrochloride), not brand-name Glucophage. Request a 90-day supply if your insurer or pharmacy allows it, as the per-unit cost drops with larger quantities.

Compare prices across at least three pharmacies. Walmart's $4 generic list, Costco's pharmacy pricing, and an online discount card comparison (GoodRx, RxSaver) will identify the lowest option in your area. If you have insurance, check whether your plan's mail-order pharmacy offers a $0 copay for 90-day generic fills.

For Delaware Medicaid enrollees, ensure your prescriber submits prior authorization promptly. The PA process is straightforward and approval rates for metformin exceed 95%. If PA is denied (rare), the appeal process through the Diamond State Health Plan typically resolves within 10 business days.

Patients using telehealth platforms should compare total cost: consultation fee plus medication cost. Some platforms bundle both. A $50 telehealth visit plus $4 for metformin at Walmart ($54 total) may be cheaper than a $150 in-person visit with a $3 copay ($153 total) for uninsured or high-deductible patients.

The cheapest path for a Delaware resident without insurance: telehealth consultation ($30 to $50), generic metformin IR prescription, fill at Walmart or Costco ($4), total first-month cost of $34 to $54, then $4 per month ongoing.